Oliviero James F III's Form 4 filing
Checkpoint Therapeutics, Inc. (CKPT) · filed Feb 2, 2024
- Accession no.
- 0001104659-24-010265
- Filed
- Feb 2, 2024
- Trade date
- Feb 1, 2024
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Not checked
This filing lists 2 non-derivative transactions. Open-market sales total $23.9K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Oliviero James F IIICIK 0001434718 | Director, Officer (CEO, President and Director) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Feb 1, 2024 | COMMON STOCK | SSaleDisposed | −11,900 | $2.01F2 | −$23,919 | 369,680 | Direct | |
| Feb 1, 2024 | COMMON STOCK | GGiftDisposed | −12,950 | $0.00 | $0 | 356,730 | Direct |
Footnotes and remarks
Livermore keeps the footnotes that transaction prices refer to, all footnotes of amendments (Form 4/A) and the filing's remarks. Other footnotes, such as how indirect holdings are held or the details of a trading plan, are only in the original on SEC EDGAR.
- F2
Represents the weighted average price of the shares sold in this transaction. The range of prices for such transaction was $2.00 to $2.0104. The reporting person undertakes to provide upon request by the Securities and Exchange Commission staff, the issuer, or a shareholder of the issuer, full information regarding the number of shares sold at each separate price.
Referenced by the price of 1 transaction in Table I.